OPHTA-SURGERY
ActiveOPHTA-SURGERY has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.98M and a net result of €457k. Equity is shrinking by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 49% of 2324 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
79
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86▲+5
Solvency84▼-2
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €150k at 30 days acceptable
Liquidity short (current ratio 0.84 against 0.97 in 2024; short-term debt: 40.3% and cash: 15.4% of total assets), and 41.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
58.9%
Return on assets
13.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-08-2026, 3 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
3 d late
2024
13 d late
2023
28 d late
2022
30 d late
2021
59 d late
2020
31 d late
2019
87 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€457k▲ 32.6%
2024 · €345k
2018: €351k
2019: €369k
2020: €315k
2021: €325k
2022: €348k
2023: €340k
2024: €345k
2018 → 2025
Working capital
€-219k▼ 379%
2024 · €-46k
2018: €1.13M
2019: €1.47M
2020: €799k
2021: €724k
2022: €916k
2023: €693k
2024: €-46k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€2.54M-€2.75M▲ 8.1%€2.91M▲ 5.7%€2.16M▼ 25.6%€1.98M▼ 8.4%
Operating result€509k-€514k▲ 1.1%€486k▼ 5.5%€547k▲ 12.6%€667k▲ 21.9%
Net result€325k-€348k▲ 7.3%€340k▼ 2.2%€345k▲ 1.2%€457k▲ 32.6%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 22% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.37M
Fixed assets
€2.23M▼ 0.4%
Current assets
€1.14M▼ 12.7%
Equity and liabilities €3.37M
Equity
€1.98M▼ 8.4%
Provisions
€30k▲ 2.9%
Debt
€1.36M▲ 0.6%
The debt ratio rises from 38.1% to 40.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€714k▲
2024 · €601k
Cash flow
€504k▲
2024 · €399k
Solvency
58.9%▼
2024 · 61.1%
Current ratio
0.84▼
2024 · 0.97
Quick ratio
0.84▼
2024 · 0.97
Debt / equity
0.68▲
2024 · 0.62
ROE
23.1%▲
2024 · 15.9%
ROA
13.6%▲
2024 · 9.7%
Interest coverage
21.74▲
2024 · 16.18
Debt
€1.36M▲
2024 · €1.35M
Debt ≤ 1 year
€1.36M▲
2024 · €1.35M
Income taxes
€222k▲
2024 · €206k
Staff costs
€24k▲
2024 · €21k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.54M€3.37M▼
Fixed assets21/28€2.24M€2.23M▼
Tangible fixed assets22/27€183k€136k▼
Plant, machinery and equipment23€64k€42k▼
Furniture and vehicles24€100k€75k▼
Other tangible fixed assets26€20k€18k▼
Financial fixed assets28€2.06M€2.09M▲
Current assets29/58€1.30M€1.14M▼
Amounts receivable within one year40/41€227k€260k▲
Trade receivables40€181k€160k▼
Other amounts receivable41€46k€100k▲
Current investments50/53€289k€349k▲
Cash at bank and in hand54/58€777k€518k▼
Deferred charges and accrued income490/1€9k€10k▲
Equity and liabilities
Total equity and liabilities10/49€3.54M€3.37M▼
Equity10/15€2.16M€1.98M▼
Contributions10/11€14k€14k=
Reserves13€2.15M€1.97M▼
Tax-exempt reserves132€738€738=
Distributable reserves133€2.15M€1.97M▼
Provisions and deferred taxes16€29k€30k▲
Provisions for liabilities and charges160/5€29k€30k▲
Other liabilities and charges164/5€29k€30k▲
Amounts payable17/49€1.35M€1.36M▲
Amounts payable within one year42/48€1.35M€1.36M▲
Financial debts43€2k-
Credit institutions430/8€2k-
Trade debts44€172k€197k▲
Suppliers440/4€172k€197k▲
Taxes, remuneration and social security45€292k€42k▼
Taxes450/3€286k€37k▼
Remuneration and social security454/9€6k€5k▼
Other amounts payable47/48€882k€1.12M▲
Income statement
Code20242025
Remuneration, social security and pensions62€21k€24k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54k€47k▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€-336€846▲
Other operating charges640/8€1k€998▼
Gross operating margin9900€624k€740k▲
Operating profit (loss)9901€547k€667k▲
Financial income75/76B€40k€45k▲
Recurring financial income75€40k€45k▲
Financial charges65/66B€37k€33k▼
Recurring financial charges65€37k€33k▼
Profit (loss) for the period before taxes9903€551k€679k▲
Income taxes67/77€206k€222k▲
Profit (loss) for the period9904€345k€457k▲
Transfer from tax-exempt reserves789€147k-
Profit (loss) for the period to be appropriated9905€492k€457k▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.39M€457k▼
Profit (loss) brought forward from the previous period14P€901k-
Transfer from equity791/2€188k€640k▲
Transfer to equity691/2€492k€457k▼
To other reserves6921€492k€457k▼
Profit to be distributed694/7€1.09M€640k▼
Return on contributions (dividend)694€1.09M€640k▼
Social balance
Average headcount (FTE)90870.7-
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 3 days late
2025
31-12
Financial
Highest result since 2018net €457k ▲32.6%
Operating result €667k, net result €457k, both a record.
13-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 13 days late
2024
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 28 days late
2023
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 30 days late
2022
28-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 59 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Weakest financial yearnet €315k ▼14.6%
Net result drops to €315k, the lowest in the series; recovery starts the following year.
26-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 87 days late
2019
23-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 54 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 2 establishment units since 1998
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Adolphe Buyllaan 110A1050 ElseneGround area
4,973 m²
Building footprint
668 m²
Volume, LiDAR
1,831 m³
2 parcels, Brussels, Flanders · tallest building 11.8 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
OPHTA-SURGERY
since 19982.342.580.187
Astridlaan 73, 1640 Sint-Genesius-Rode
since 20202.361.409.768
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22552E0043/00W053 | Flanders | 3,702 m² | 1 · 249 m² | 11.8 m · 2 fl. |
| 21445C0261/00F002 | Brussels | 1,271 m² | 1 · 418 m² | 2.4 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9845006EFT00EA679941
Similar companies · same sector, comparable size
DR. RENS BUSSCHOTS EN DR. EVELIEN DEWILDE
BE 0674.417.145
Hasselt · Eq €1.98M
Dr. Dirven werner
BE 0808.735.322
Vosselaar · Eq €1.98M
B.G. OPHTALMO
BE 0465.894.562
Watermaal-Bosvoorde · Eq €1.98M
DR. VANDERKERKEN - DR. DECRAENE
BE 0873.672.961
Sint-Truiden · Eq €1.99M
X-RAYS MEDICAL
BE 0773.586.579
Beyne-Heusay · Eq €1.99M
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 4,643 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-02-1998
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 28 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.